title: Long-term significance (15 years) of pathological complete response after dose-dense neoadjuvant chemotherapy in breast cancer.
authors.forename: Qian
authors.initials: Q
authors.lastname: Wang-Lopez
authors.forename: Catherine
authors.initials: C
authors.lastname: Abrial
authors.forename: Eloïse
authors.initials: E
authors.lastname: Planchat
authors.forename: Marie-Ange
authors.initials: MA
authors.lastname: Mouret-Reynier
authors.forename: Hervé
authors.initials: H
authors.lastname: Cure
authors.forename: Pierre
authors.initials: P
authors.lastname: Gimbergues
authors.forename: Pascale
authors.initials: P
authors.lastname: Dubray-Longeras
authors.forename: Emilie
authors.initials: E
authors.lastname: Gadea
authors.forename: Fabrice
authors.initials: F
authors.lastname: Kwiatkowski
authors.forename: Frédérique
authors.initials: F
authors.lastname: Penault-Llorca
authors.forename: Philippe
authors.initials: P
authors.lastname: Chollet
authors.forename: Xavier
authors.initials: X
authors.lastname: Durando
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality* / Q000473:pathology* / Q000601:surgery; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D058922:Inflammatory Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D015996:Survival Rate; D016896:Treatment Outcome; D055815:Young Adult